Therapeutic potential of erythropoietin and its structural or functional variants in the nervous system

No abstract is available for this paper.

• Publication year

  2011

• Venue

  Neurotherapeutics

• Publication date

  Unknown publication date

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/j.nurt.2008.10.041PMID 19110203PMCID PMC5084260
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• A Phase I/II Trial of High-Dose Erythropoietin in Extremely Low Birth Weight Infants: Pharmacokinetics and Safety

  2009cited by this paper
• High levels of erythropoietin are associated with protection against neurological sequelae in African children with cerebral malaria

  2008cited by this paper
• Therapeutic window for nonerythropoietic carbamylated-erythropoietin to improve motor function following multiple infarct ischemic strokes in New Zealand white rabbits.

  2008cited by this paper
• Intravitreal injection of erythropoietin protects both retinal vascular and neuronal cells in early diabetes.

  2008cited by this paper
• Neuroprotection in Diet-Induced Ketotic Rat Brain after Focal Ischemia

  2008cited by this paper
• Erythropoietin deficiency decreases vascular stability in mice.

  2008cited by this paper
• High-dose erythropoietin alters platelet reactivity and bleeding time in rodents in contrast to the neuroprotective variant carbamyl-erythropoietin (CEPO)

  2008cited by this paper
• Erythropoietin enhances hippocampal long-term potentiation and memory

  2008cited by this paper
• Pure red cell aplasia induced by erythropoiesis-stimulating agents.

  2008cited by this paper
• A Phase I/II Trial of High-Dose Erythropoietin in Extremely Low Birth Weight Infants: Pharmacokinetics and Safety

  2008cited by this paper
• Erythropoietin and its carbamylated derivative prevent the development of experimental diabetic autonomic neuropathy in STZ-induced diabetic NOD-SCID mice.

  2008cited by this paper
• Recombinant human erythropoietin increases survival and reduces neuronal apoptosis in a murine model of cerebral malaria

  2008cited by this paper
• The non‐haematopoietic biological effects of erythropoietin

  2008cited by this paper
• Developments in the therapeutic use of erythropoiesis stimulating agents

  2008cited by this paper
• An Approach to Using Recombinant Erythropoietin for Neuroprotection in Very Preterm Infants

  2008cited by this paper
• Essential role for Stat5 in the neurotrophic but not in the neuroprotective effect of erythropoietin

  2008cited by this paper
• Venous thromboembolism and mortality associated with recombinant erythropoietin and darbepoetin administration for the treatment of cancer-associated anemia.

  2008cited by this paper
• Nonerythropoietic, tissue-protective peptides derived from the tertiary structure of erythropoietin

  2008cited by this paper
• VTE and mortality associated with erythropoiesis-stimulating agents in cancer-associated anemia

  2008cited by this paper
• A re-assessment of erythropoietin as a neuroprotective agent following rat spinal cord compression or contusion injury.

  2008cited by this paper
• Erythropoietin augments survival of glioma cells after radiation and temozolomide.

  2008cited by this paper
• Neurological effects of recombinant human erythropoietin in Friedreich's ataxia: A clinical pilot trial

  2008cited by this paper
• Stimulating Erythropoiesis: Future Perspectives

  2008cited by this paper
• A "classical" homodimeric erythropoietin receptor is essential for the antiapoptotic effects of erythropoietin on differentiated neuroblastoma SH-SY5Y and pheochromocytoma PC-12 cells.

  2007influential reference
• Effects of Erythropoietin on Posttraumatic Place Learning in Fimbria-Fornix Transected Rats after a 30-Day Postoperative Pause

  2007cited by this paper
• Friedreich's ataxia: clinical pilot trial with recombinant human erythropoietin

  2007cited by this paper
• Improvement of cognitive functions in chronic schizophrenic patients by recombinant human erythropoietin

  2007influential reference
• Darbepoetin alfa (Aranesp) improves recognition memory in adult rats that have sustained bilateral ventral hippocampal lesions as neonates or young adults.

  2007cited by this paper
• Inhibitory effect on cerebral inflammatory agents that accompany traumatic brain injury in a rat model: a potential neuroprotective mechanism of recombinant human erythropoietin (rhEPO).

  2007influential reference
• Pharmacokinetics of High-Dose Recombinant Erythropoietin in Plasma and Brain of Neonatal Rats

  2007cited by this paper
• Treatment of traumatic brain injury in rats with erythropoietin and carbamylated erythropoietin.

  2007cited by this paper
• The Sonic Hedgehog Pathway Mediates Carbamylated Erythropoietin-enhanced Proliferation and Differentiation of Adult Neural Progenitor Cells*

  2007cited by this paper
• Post‐ischemic treatment with erythropoietin or carbamylated erythropoietin reduces infarction and improves neurological outcome in a rat model of focal cerebral ischemia

  2007influential reference
• Erythropoietin delays disease onset in an amyotrophic lateral sclerosis model.

  2007cited by this paper
• Erythropoietin in patients with aneurysmal subarachnoid haemorrhage: a double blind randomised clinical trial

  2007cited by this paper
• Neuroprotection by erythropoietin administration after experimental traumatic brain injury.

  2007influential reference
• Recombinant human erythropoietin administration protects cortical neurons from traumatic brain injury in rats

  2007cited by this paper
• Neuroprotection with Erythropoietin Administration Following Controlled Cortical Impact Injury in Rats

  2007cited by this paper
• Survival and invasiveness of astrocytomas promoted by erythropoietin.

  2007cited by this paper
• Erythropoietin and carbamylated erythropoietin are neuroprotective following spinal cord hemisection in the rat

  2007cited by this paper
• Neuroprotective potential of erythropoietin and darbepoetin alfa in an experimental model of sciatic nerve injury. Laboratory investigation.

  2007cited by this paper
• Reduced Functional Deficits, Neuroinflammation, and Secondary Tissue Damage after Treatment of Stroke by Nonerythropoietic Erythropoietin Derivatives

  2007cited by this paper
• A Novel Class of Prolyl Hydroxylase Inhibitors Induces Angiogenesis and Exerts Organ Protection Against Ischemia

  2007cited by this paper
• Exploring recombinant human erythropoietin in chronic progressive multiple sclerosis.

  2007cited by this paper
• Erythropoietin Enhances Long-Term Neuroprotection and Neurogenesis in Neonatal Stroke

  2007cited by this paper
• Role of erythropoietin in the brain.

  2007cited by this paper
• Erythropoietin Protects from Post-Traumatic Edema in the Rat Brain

  2007influential reference
• Endogenous Erythropoietin Signaling Is Required for Normal Neural Progenitor Cell Proliferation*

  2007cited by this paper
• Brain Erythropoietin Receptor Expression in Alzheimer Disease and Mild Cognitive Impairment

  2007cited by this paper
• Exogenous erythropoietin provides neuroprotection of grafted dopamine neurons in a rodent model of Parkinson's disease.

  2006cited by this paper
• Global brain atrophy after unilateral parietal lesion and its prevention by erythropoietin.

  2006cited by this paper
• Erythropoietin reduces Schwann cell TNF‐α, Wallerian degeneration and pain‐related behaviors after peripheral nerve injury

  2006cited by this paper
• A Critical Role of Erythropoietin Receptor in Neurogenesis and Post-Stroke Recovery

  2006cited by this paper
• Apoptosis dominant in the periinfarct area of human ischaemic stroke--a possible target of antiapoptotic treatments.

  2006cited by this paper
• Delayed administration of erythropoietin and its non-erythropoietic derivatives ameliorates chronic murine autoimmune encephalomyelitis.

  2006cited by this paper
• Recombinant human erythropoietin prevents the death of mice during cerebral malaria.

  2006cited by this paper
• Preclinical evaluation of Hematide, a novel erythropoiesis stimulating agent, for the treatment of anemia.

  2006cited by this paper
• Amelioration of spinal cord compressive injury by pharmacological preconditioning with erythropoietin and a nonerythropoietic erythropoietin derivative.

  2006cited by this paper
• The Brain Erythropoietin System and its Potential for Therapeutic Exploitation in Brain Disease

  2006cited by this paper
• Nonhematopoietic Erythropoietin Derivatives Prevent Motoneuron Degeneration In Vitro and In Vivo

  2006cited by this paper
• UNRESOLVED ISSUES IN DIALYSIS: Managing Erythropoietin Hyporesponsiveness

  2006cited by this paper
• Carbamylated Erythropoietin Reduces Radiosurgically-Induced Brain Injury

  2006cited by this paper
• Emerging biological roles for erythropoietin in the nervous system

  2005cited by this paper
• Erythropoietin as a retinal angiogenic factor in proliferative diabetic retinopathy.

  2005cited by this paper
• The pharmacokinetics of erythropoietin in the cerebrospinal fluid after intravenous administration of recombinant human erythropoietin

  2005cited by this paper
• Intranasal recombinant human erythropoietin protects rats against focal cerebral ischemia.

  2005cited by this paper
• treatment of

  2005cited by this paper
• Antioxidant properties of propofol and erythropoietin after closed head injury in rats.

  2005cited by this paper
• Maintaining normal hemoglobin levels with epoetin alfa in mainly nonanemic patients with metastatic breast cancer receiving first-line chemotherapy: a survival study.

  2005cited by this paper
• Erythropoietin treatment improves neurological functional recovery in EAE mice.

  2005cited by this paper
• Hypoxia-inducible Factor Prolyl 4-Hydroxylase Inhibition

  2005cited by this paper
• Erythropoietin Requires NF-κB and its Nuclear Translocation to Prevent Early and Late Apoptotic Neuronal Injury During β-Amyloid Toxicity

  2005cited by this paper
• Erythropoietin Improves Functional and Histological Outcome in Neonatal Stroke

  2005cited by this paper
• Cannabidiol Prevents Cerebral Infarction Via a Serotonergic 5-Hydroxytryptamine1A Receptor–Dependent Mechanism

  2005cited by this paper
• Erythropoietin prevents long-term sensorimotor deficits and brain injury following neonatal hypoxia-ischemia in rats.

  2005cited by this paper
• Neuroprotective Effect of Darbepoetin Alfa, a Novel Recombinant Erythropoietic Protein, in Focal Cerebral Ischemia in Rats

  2005cited by this paper
• Erythropoietin requires NF-kappaB and its nuclear translocation to prevent early and late apoptotic neuronal injury during beta-amyloid toxicity.

  2005cited by this paper
• Effect of erythropoietin axotomy-induced apoptosis in rat retinal ganglion cells.

  2004cited by this paper
• HIF1 and oxygen sensing in the brain

  2004cited by this paper
• Derivatives of Erythropoietin That Are Tissue Protective But Not Erythropoietic

  2004cited by this paper
• Erythropoietin and the hypoxic brain

  2004cited by this paper
• Treatment of Stroke With Erythropoietin Enhances Neurogenesis and Angiogenesis and Improves Neurological Function in Rats

  2004cited by this paper
• Expression patterns of erythropoietin and its receptor in the developing midbrain

  2004cited by this paper
• Asialoerythropoetin is not effective in the R6/2 line of Huntington's disease mice

  2004cited by this paper
• Combined therapy with methylprednisolone and erythropoietin in a model of multiple sclerosis.

  2004cited by this paper
• A novel endogenous erythropoietin mediated pathway prevents axonal degeneration

  2004cited by this paper
• Erythropoietin: a candidate compound for neuroprotection in schizophrenia

  2004influential reference
• Erythropoietin is neuroprotective in models of HIV sensory neuropathy.

  2004cited by this paper
• Blood pressure response to erythropoietin injection in hemodialysis and predialysis patients.

  2004cited by this paper
• Beneficial effect of erythropoietin on experimental allergic encephalomyelitis

  2004cited by this paper
• Neuroprotective effects and intracellular signaling pathways of erythropoietin in a rat model of multiple sclerosis

  2004cited by this paper
• Erythropoietin: Novel Approaches to Neuroprotection in Human Brain Disease

  2004cited by this paper
• Erythropoietin mediates tissue protection through an erythropoietin and common beta-subunit heteroreceptor.

  2004cited by this paper
• Passage of erythropoietic agents across the blood-brain barrier: a comparison of human and murine erythropoietin and the analog darbepoetin alfa.

  2004cited by this paper
• Erythropoietin improves long-term spatial memory deficits and brain injury following neonatal hypoxia-ischemia in rats.

  2004cited by this paper
• Treatment of Stroke With Erythropoietin Enhances Neurogenesis and Angiogenesis and Improves Neurological Function in Rats

  2004cited by this paper
• Erythropoietin Selectively Attenuates Cytokine Production and Inflammation in Cerebral Ischemia by Targeting Neuronal Apoptosis

  2003cited by this paper
• Darbepoetin alfa has a longer circulating half-life and greater in vivo potency than recombinant human erythropoietin.

  2003cited by this paper
• Erythropoietin protects the in vitro blood–brain barrier against VEGF‐induced permeability

  2003cited by this paper
• Pure red cell aplasia and anti-erythropoietin antibodies in patients treated with epoetin.

  2003cited by this paper

• Unusual expression of peripheral blood Alzheimer's markers, inflammatory cytokines, and cholinergic biomarkers in chronic kidney disease patients with cognitive dysfunction: Therapeutic impact of recombinant human erythropoietin (rHuEPO).

  2026cites this paper
• Epoetin alfa has a potent anxiolytic effect on naive female rats

  2025cites this paper
• The Role of Erythropoietin in Metabolic Regulation

  2025cites this paper
• Carbamoylated Erythropoietin Rescues Autism-Relevant Social Deficits in BALB/cJ Mice

  2025cites this paper
• Therapeutic strategies that modulate the acute phase of secondary spinal cord injury scarring and inflammation and improve injury outcomes

  2025cites this paper
• Intramuscular delivery of recombinant AAV expressing EpoR76E improves memory and is neuroprotective in 5xFAD transgenics

  2025cites this paper
• Overcoming Challenges in Peripheral Nerve Regeneration: A Review of Pharmaceutical Scaffold Applications

  2025cites this paper
• EPO Deficiency Upregulates GADD45b/p38 MAPK Axis, Mediating Schizophrenia‐Related Synaptic and Cognitive Impairments

  2024cites this paper
• Effects of erythropoietin on cognitive impairment and prefrontal cortex activity across affective disorders: A randomized, double-blinded, placebo-controlled trial

  2024cites this paper
• Exploring the effects of erythropoietin treatment on cortical thickness and hippocampal volume in patients with mood disorders undergoing electroconvulsive therapy: A randomized, placebo-controlled trial

  2024cites this paper
• Peripheral Nerve Regeneration: Opportunities and Challenges

  2023cites this paper
• Erythropoietin restrains the inhibitory potential of interneurons in the mouse hippocampus

  2023cites this paper
• Chemogenetic inhibition of amygdala excitatory neurons impairs rhEPO-enhanced contextual fear memory after TBI.

  2023cites this paper
• Effect of erythropoietin on cognitive side-effects of electroconvulsive therapy in depression: A randomized, double-blind, placebo-controlled trial.

  2023cites this paper
• An update on potential pharmacotherapies for cognitive impairment in bipolar disorder

  2023cites this paper
• Más allá de lo habitual: Nuevos enfoques en la terapia de la esquizofrenia resistente

  2023cites this paper
• Cerebrospinal fluid erythropoietin, oxidative stress, and cognitive functions in patients with bipolar disorder and healthy control participants: A longitudinal case-control study.

  2023cites this paper
• Inactivation of mouse transmembrane prolyl 4-hydroxylase increases blood brain barrier permeability and ischemia-induced cerebral neuroinflammation

  2022cites this paper
• Advanced drug delivery system against ischemic stroke.

  2022cites this paper
• Erythropoietin as a Neuroprotective Drug for Newborn Infants: Ten Years after the First Use

  2022cites this paper
• Introducing the brain erythropoietin circle to explain adaptive brain hardware upgrade and improved performance

  2022cites this paper
• Addressing the ‘hypoxia paradox’ in severe COVID-19: literature review and report of four cases treated with erythropoietin analogues

  2021cites this paper
• Brain erythropoietin fine-tunes a counterbalance between neurodifferentiation and microglia in the adult hippocampus.

  2021cites this paper
• Erythropoietin-derived peptide treatment reduced neurological deficit and neuropathological changes in a mouse model of tauopathy

  2021cites this paper
• Systematic Review of Erythropoietin (EPO) for Neuroprotection in Human Studies

  2021cites this paper
• Carbamylated Erythropoietin Improves Recognition Memory by Modulating Microglia in a rat model of Pain.

  2021cites this paper
• fvEarly monocyte modulation by the non-erythropoietic peptide ARA 290 decelerates AD-like pathology progression.

  2021cites this paper
• Erythropoietin Stimulates GABAergic Maturation in the Mouse Hippocampus

  2021cites this paper
• Variable alterations in plasma erythropoietin and brain-derived neurotrophic factor levels in patients with major depressive disorder with and without a history of suicide attempt.

  2021cites this paper
• Stroke Treatment: Focus on Neuroprotection and EPO

  2021cites this paper
• Procognitive Effects of Antidepressants and Other Therapeutic Agents in Major Depressive Disorder: A Systematic Review.

  2020cites this paper
• Treatment of Neonatal Hypoxic-Ischemic Encephalopathy with Erythropoietin Alone, and Erythropoietin Combined with Hypothermia: History, Current Status, and Future Research

  2020cites this paper
• The effect of erythropoietin on electroconvulsive stimulation induced cognitive impairment in rats.

  2020cites this paper
• Protective Impacts of Erythropoietin on Myelinization of Oligodendrocytes and Schwann cells in CNS and PNS following Cuprizone-Induced Multiple Sclerosis- Histology, Molecular, and Functional Studies.

  2020cites this paper
• Mosses: Versatile plants for biotechnological applications.

  2020cites this paper
• Traumatic Cranial Neuropathies

  2020cites this paper
• Functional hypoxia drives neuroplasticity and neurogenesis via brain erythropoietin

  2020cites this paper
• Novel approaches for the delivery of therapeutics in ischemic stroke.

  2020cites this paper
• Erythropoietin as candidate for supportive treatment of severe COVID-19

  2020cites this paper
• Regulation of inflammatory cytokines for spinal cord injury recovery.

  2020cites this paper
• Synthesis and labeling of p-NH2-Bn-DTPA-(Dabcyl-Lys6,Phe7)-pHBSP with 99mTc as a radiopeptide scintigraphic agent to detect cardiac ischemia

  2020cites this paper
• with 99mTc as a radiopeptide scintigraphic agent to detect cardiac ischemia Naser Mohtavinejad1 · Ahmad Bitarafan‐Rajabi2 · Mehdi Shafiee Ardestani1 · Amir Darbandi‐Azar3 · Ali Khalaj4 · Atefe Ghodrati4 · Mehdi Asadi4 · Massoud Amanlou4

  2020cites this paper
• A triple sense of oxygen promotes neurovascular angiogenesis in NG2‐derived cells

  2020cites this paper
• Neuroprotective and Neurestorative Effects of Epo and VEGF: Perspectives for New Therapeutic Approaches to Neurological Diseases.

  2020cites this paper
• Erythropoietin and Friedreich Ataxia: Time for a Reappraisal?

  2019cites this paper
• Emergent Prophylactic, Reparative and Restorative Brain Interventions for Infants Born Preterm With Cerebral Palsy

  2019cites this paper
• Whole-Brain Exploratory Analysis of Functional Task Response Following Erythropoietin Treatment in Mood Disorders: A Supervised Machine Learning Approach

  2019cites this paper
• Genes Encoding Erythropoietin and Its Receptor in Bipolar I (Manic Phase) Patients as a Novel Diagnostic Agent: A Case-Control Study

  2019cites this paper
• Short erythropoietin-derived peptide enhances memory, improves long-term potentiation, and counteracts amyloid beta-induced pathology.

  2019cites this paper
• Improvement of Memory Deficits in the Rat Model of Alzheimer's Disease by Erythropoietin-Loaded Solid Lipid Nanoparticles.

  2019cites this paper
• Parkinson Disease 1 ERP sources in middle cingulate and precuneus differentiate Parkinson ’ s patients from 2 healthy controls and lingual gyri sources reflect human recombinant EPO effects in a 3 Flanker task 4

  2019cites this paper
• Flanker Task-Elicited Event-Related Potential Sources Reflect Human Recombinant Erythropoietin Differential Effects on Parkinson's Patients

  2019cites this paper
• Investigating novel therapies for Friedreich’s ataxia

  2018cites this paper
• Visual-Evoked-Response-Supported Outcome of Intravitreal Erythropoietin in Management of Indirect Traumatic Optic Neuropathy

  2018cites this paper
• Erythropoietin as an add-on treatment for cognitive side effects of electroconvulsive therapy: a study protocol for a randomized controlled trial

  2018cites this paper
• GSK3β: a plausible mechanism of cognitive and hippocampal changes induced by erythropoietin treatment in mood disorders?

  2018cites this paper
• Erythropoietin Induces Homeostatic Plasticity at Hippocampal Synapses

  2018cites this paper
• Cognitive, emotional and social phenotyping of mice in an observer‐independent setting

  2018cites this paper
• 7 Current Advances in Cerebral Malaria Associated Encephalopathy

  2018cites this paper
• CEPO-Fc (An EPO Derivative) Protects Hippocampus Against Aβ-induced Memory Deterioration: A Behavioral and Molecular Study in a Rat Model of Aβ Toxicity.

  2018cites this paper
• Effects of erythropoietin abuse on exercise performance

  2018cites this paper
• Computational analysis of ligand–receptor interactions in wild-type and mutant erythropoietin complexes

  2018cites this paper
• Title: Neural correlates of improved recognition of happy faces after erythropoietin treatment in bipolar disorder Running title: EPO: neural response to faces in bipolar disorder

  2018cites this paper
• Neural correlates of improved recognition of happy faces after erythropoietin treatment in bipolar disorder

  2018cites this paper
• Effects of recombinant human erythropoietin on cognition and neural activity in remitted patients with mood disorders and first-degree relatives of patients with psychiatric disorders: a study protocol for a randomized controlled trial

  2018cites this paper
• Erythropoietin Upregulates Brain Hemoglobin Expression and Supports Neuronal Mitochondrial Activity

  2018cites this paper
• Qi Fu Yin–a Ming Dynasty Prescription for the Treatment of Dementia

  2018cites this paper
• NeuroEPO Preserves Neurons from Glutamate-Induced Excitotoxicity

  2018cites this paper
• The progress of prophylactic treatment in retinopathy of prematurity.

  2018cites this paper
• Erythropoietin and Nonhematopoietic Effects

  2017cites this paper
• Rufinamide in children and adults in routine clinical practice

  2017cites this paper
• Erythropoietin Increases Myelination in Oligodendrocytes: Gene Expression Profiling Reveals Early Induction of Genes Involved in Lipid Transport and Metabolism

  2017cites this paper
• Erythropoietin induces homeostatic plasticity at hippocampal synapses. Cerebral Cortex

  2017cites this paper
• Évaluation et prise en charge des troubles émotionnels par le biais des nouvelles technologies. (New technologies to assess and take care emotional disorders)

  2017cites this paper
• The Effect of Combined Systemic Erythropoietin and Steroid on Non-arteritic Anterior Ischemic Optic Neuropathy: A Prospective Study

  2017cites this paper
• Inflammation and neurotransmission in mesial temporal lobe epilepsy

  2017cites this paper
• Erythropoietin is Neuroprotective During Ongoing Compression and Speeds Recovery Following Surgical Decompression in a Murine Model of Chronic Compression Neuropathy: N/A - Not a clinical study

  2016cites this paper
• Revisiting adult neurogenesis and the role of erythropoietin for neuronal and oligodendroglial differentiation in the hippocampus

  2016cites this paper
• Exploring Erythropoietin and G-CSF Combination Therapy in Chronic Stroke Patients

  2016cites this paper
• Erythropoietin Pathway: A Potential Target for the Treatment of Depression

  2016cites this paper
• Effects of erythropoietin on memory‐relevant neurocircuitry activity and recall in mood disorders

  2016cites this paper
• The effect of erythropoietin on cognition in affective disorders - Associations with baseline deficits and change in subjective cognitive complaints.

  2016cites this paper
• [Relationship between serum erythropoietin levels and brain injury in preterm infants].

  2016cites this paper
• Treatment of optic neuritis with erythropoietin (TONE): a randomised, double-blind, placebo-controlled trial—study protocol

  2016influential citation
• Neuroprotective Effect of Erythropoietin on Phenylhydrazine-Induced Hemolytic Hyperbilirubinemia in Neonatal Rats

  2016cites this paper
• Carbamylated erythropoietin enhances mice ventilatory responses to changes in O2 but not CO2 levels.

  2016cites this paper
• Drugs for neuroprotection after birth asphyxia: Pharmacologic adjuncts to hypothermia.

  2016cites this paper
• Neonatal brain injury as a consequence of insufficient cerebral oxygenation.

  2016cites this paper
• Erythropoietin Protects Rat Brain Injury from Carbon Monoxide Poisoning by Inhibiting Toll-Like Receptor 4/NF-kappa B-Dependent Inflammatory Responses

  2016cites this paper
• The AMPA receptor antagonist perampanel robustly rescues amyotrophic lateral sclerosis (ALS) pathology in sporadic ALS model mice

  2016cites this paper
• Is erythropoietin a worthy candidate for traumatic brain injury or are we heading the wrong way?

  2016cites this paper
• DNA methylation in Huntington's disease: Implications for transgenerational effects.

  2016influential citation
• Neural correlates of improved executive function following erythropoietin treatment in mood disorders

  2016influential citation
• Towards new mechanisms: an update on therapeutics for treatment-resistant major depressive disorder

  2015cites this paper
• Erythropoietin as an Innovative Add-on Therapy for Depression.

  2015cites this paper
• Neuroprotective Potential of Erythropoietin as an Adjuvant to Decompression for Chronic Compression Neuropathy: N/A - Not a clinical study

  2015cites this paper
• Moss‐made pharmaceuticals: from bench to bedside

  2015cites this paper
• Anti-edema effects of rhEpo in experimental traumatic brain injury

  2015cites this paper
• Widespread Expression of Erythropoietin Receptor in Brain and Its Induction by Injury

  2015cites this paper
• Assessment of Endogenous Erythropoietin Level in Sera Patients with Acute Ischemic Stroke

  2015cites this paper